|
NG-MAST ST (No. of isolates)
|
Anti-microbial
|
No. of isolates with MIC (mg/L):
|
|---|
| | |
≤0.016
|
0.032
|
0.064
|
0.125
|
0.25
|
|---|
|
4787 (11)
|
IX
| |
3
|
4
|
3
|
1
|
| |
TX
| | |
3
|
5
|
3
|
|
7720 (5)a
|
IX
|
1
|
4
| | | |
| |
TX
| |
5
| | | |
|
7741 (4)a
|
IX
| | |
3
|
1
| |
| |
TX
| | | |
4
| |
|
7155 (3)a
|
IX
| |
1
|
2
| | |
| |
TX
| |
2
|
1
| | |
|
7724 (3)a
|
IX
| |
3
| | | |
| |
TX
| | |
3
| | |
|
3493 (2)
|
IX
|
2
| | | | |
| |
TX
|
2
| | | | |
|
7139 (2)a
|
IX
|
2
| | | | |
| |
TX
|
2
| | | | |
|
7140 (2)a
|
IX
| |
1
|
1
| | |
| |
TX
| |
2
| | | |
|
7159 (2)a
|
IX
| | |
2
| | |
| |
TX
| | | |
1
|
1
|
|
7718 (2)a
|
IX
| | |
2
| | |
| |
TX
| | | |
2
| |
|
7722 (2)a
|
IX
|
2
| | | | |
| |
TX
| |
2
| | | |
|
7731 (2)a
|
IX
| |
2
| | | |
| |
TX
| |
2
| | | |
|
7734 (2)a
|
IX
| | |
2
| | |
| |
TX
| | |
1
|
1
| |
|
7735 (2)a
|
IX
| |
2
| | | |
| |
TX
| |
1
|
1
| | |
|
7736 (2)a
|
IX
| |
1
|
1
| | |
| |
TX
| | |
2
| | |
|
7739 (2)a
|
IX
| | | |
2
| |
| |
TX
| | | |
2
| |
|
7748 (2)a
|
IX
| |
1
|
1
| | |
| |
TX
| |
1
|
1
| | |
|
Unique STs (58)b
|
IX
|
15
|
16
|
25
|
2
| |
| |
TX
|
12
|
15
|
20
|
10
|
1
|
- NG-MAST, Neisseria gonorrhoeae multiantigen sequence typing; ST, sequence type;
- MIC, minimum inhibitory concentration; IX, cefixime; TX, ceftriaxone.
-
aNew sequence types found in the present study.
-
bUnique STs represented by single isolates.
